Although the primary outcome was not statistically different between a liberal and more restrictive transfusion strategy, secondary results suggest some advantages for the liberal approach.
HeartBeam Announces Expansion of Its Scientific Advisory Board tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Patients with Guardian™ System alarms active experienced a substantial increase in new prescriptions or medication adjustments related to rate and rhythm.
/PRNewswire/ Amgen (NASDAQ:AMGN) today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA.